ArriVent BioPharma (AVBP) Earnings Date & Reports

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AVBP is expected to report earnings to fall 4.17% to -92 cents per share on August 18

ArriVent BioPharma AVBP Stock Earnings Reports

Q2'26

Est.

$-0.92

Q1'26

Missed

by $0.12

Q4'25

Missed

by $0.02

Q3'25

Missed

by $0.04

Q2'25

Missed

by $0.14

The last earnings report on May 11 showed earnings per share of -95 cents, missing the estimate of -83 cents. With 439.54K shares outstanding, the current market capitalization sits at 1.52B.

View a ticker or compare two or three

Compare

AVBP

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for AVBP